Genprex, Inc. (GNPX)
3.48
+0.06
(+1.61%)
USD |
NASDAQ |
Sep 04, 14:31
Genprex Price : 3.48 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 03, 2026 | 3.52 | 3.57 | 3.37 | 3.425 | 48623.00 |
| Sep 02, 2026 | 3.51 | 3.61 | 3.49 | 3.51 | 39969.00 |
| Sep 01, 2026 | 3.62 | 3.64 | 3.46 | 3.55 | 41393.00 |
| Aug 31, 2026 | 3.73 | 3.84 | 3.63 | 3.71 | 40740.00 |
| Aug 28, 2026 | 3.68 | 3.75 | 3.630 | 3.67 | 55896.00 |
| Aug 27, 2026 | 3.95 | 4.02 | 3.57 | 3.61 | 197359.0 |
| Aug 26, 2026 | 3.99 | 4.07 | 3.930 | 3.97 | 28356.00 |
| Aug 25, 2026 | 4.02 | 4.170 | 3.950 | 4.00 | 72205.00 |
| Aug 24, 2026 | 4.02 | 4.12 | 3.936 | 4.02 | 54102.00 |
| Aug 21, 2026 | 3.90 | 4.289 | 3.86 | 3.95 | 96475.00 |
| Aug 20, 2026 | 3.99 | 4.05 | 3.880 | 3.95 | 71568.00 |
| Aug 19, 2026 | 3.86 | 4.16 | 3.85 | 3.99 | 212240.0 |
| Aug 18, 2026 | 4.24 | 4.83 | 3.83 | 3.95 | 4.292M |
| Aug 17, 2026 | 4.20 | 4.892 | 4.06 | 4.475 | 446669.0 |
| Aug 14, 2026 | 4.92 | 4.92 | 4.255 | 4.32 | 90925.00 |
| Aug 13, 2026 | 4.69 | 5.237 | 4.68 | 4.87 | 103584.0 |
| Aug 12, 2026 | 4.43 | 4.85 | 4.251 | 4.73 | 73830.00 |
| Aug 11, 2026 | 4.06 | 4.74 | 4.06 | 4.47 | 158245.0 |
| Aug 10, 2026 | 4.46 | 4.575 | 4.02 | 4.19 | 119167.0 |
| Aug 07, 2026 | 4.31 | 4.474 | 4.24 | 4.27 | 77631.00 |
| Aug 06, 2026 | 4.45 | 4.55 | 4.00 | 4.44 | 148145.0 |
| Aug 05, 2026 | 4.24 | 4.56 | 4.150 | 4.44 | 106170.0 |
| Aug 04, 2026 | 4.68 | 4.94 | 4.11 | 4.42 | 409081.0 |
| Aug 03, 2026 | 5.06 | 5.458 | 4.65 | 4.75 | 2.818M |
| Jul 31, 2026 | 6.02 | 6.256 | 5.63 | 5.99 | 29018.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 28.08 |
| Alnylam Pharmaceuticals, Inc. | 265.31 |
| Anika Therapeutics, Inc. | 20.87 |
| Savara, Inc. | 5.37 |
| Vericel Corp. | 40.02 |
Price Related Metrics
| Price to Book Value | 0.1191 |
| Earnings Yield | -4.56K% |
| Market Cap | 1.762M |